用单独使用梅波利祖马布治疗慢性异常性爱因素型肺炎,而不使用皮质类固醇
Katharina Moritz1, Carolina Amelunxen1, Michael Bergmann1
1Medical Department II with Pneumology and Karl-Landsteiner Institute for Pneumology and Pulmonary Oncology, Klinik Ottakring, Montleartstraße 37, Pavillon 26 | Ebene B, 1160, Vienna, Austria.
Wiener klinische Wochenschrift
|August 8, 2024
概括
梅波利祖马布 (Mepolizumab) 是一种抗联素-5疗法,有效地治疗了慢性异常性异敏性肺炎 (CIEP),没有使用类固醇. 这种新的方法导致了症状的缓解,并在患有CIEP的患者中持续两年无复发期.
科学领域:
- 肺部病理学 肺部病理学
- 免疫学 免疫学 免疫学
- 药理学 药理学是指药理学的学科.
背景情况:
- 慢性异常性埃索诺菲尔性肺炎 (CIEP) 通常使用葡萄糖皮质类药物进行治疗.
- 长期使用葡萄糖皮质醇与显著的不良影响有关.
- 需要对CIEP进行替代治疗.
研究的目的:
- 评估mepolizumab,一种抗列素-5单克隆抗体,作为对CIEP的无皮质类固醇治疗.
- 评估mepolizumab在一个拒绝葡萄糖皮质类药物治疗的CIEP患者的疗效和安全性.
主要方法:
- 一个50岁妇女被诊断患有CIEP的案例研究.
- 评估了临床表现,实验室发现和成像.
- 梅波利祖马布的治疗始于没有同时或之前使用葡萄糖皮质激素.
- 在为期两年的随访期间,对患者的结果进行了监测.
主要成果:
- 梅波利祖马布治疗导致CIEP症状完全消失.
- 在梅波利祖马布治疗后,放射学发现显著改善.
- 患者在没有暴露于葡萄糖皮质醇的情况下保持两年没有复发.
- 在治疗期间没有报告任何重大不良事件.
结论:
- 梅波利祖马布证明了作为慢性异常性异osinophilic 肺炎的无皮质类固醇治疗的显著疗效.
- 这一案例突出显示了抗干白素-5治疗罕见呼吸道疾病的潜力.
- 进一步的研究是有必要的,以探索抗IL-5药物在管理CIEP和类似的条件.
相关概念视频
01:26COPD: Management Using Bronchodilators and Corticosteroids
192
Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
192
01:25Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
261
Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
261
01:30Asthma-IV: Diagnostic and Management
2.5K
The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
2.5K
01:17Drugs Used in Lower Respiratory Disorders: Overview
383
Lower respiratory tract disorders present challenges that often require skilled and nuanced approaches for effective management. Common ailments, such as asthma and chronic obstructive pulmonary disease (COPD), have prompted the development of intricate treatment strategies involving bronchodilators and anti-inflammatory drugs, each tailored to ease breathing and revitalize the lungs.
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
383
01:20Chronic Obstructive Pulmonary Disease-II: Pathophysiology
2.7K
Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Chronic Inflammation
2.7K
01:20COPD: Pathogenesis and Clinical Features
248
Chronic obstructive pulmonary disease (COPD) is a group of lung conditions that progressively worsen over time, including chronic bronchitis and emphysema. This cluster of diseases collectively leads to a gradual and irreversible decline in lung function over time.
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
248